Physician
Radiology
Dr. Robert Beauchamp, MD
|
|
Give Review
Robert Beauchamp practices Radiology. He has 5 awards "America's Top Doctors", "Nashville Lifestyles Magazine", "America's Top Doctors for Cancer", "Elected Member" and "Redbook Magazine: Top Breast Cancer Doctors". Doctor Robert Beauchamp, MD is also a published physician. He has 37 publication published. The most recent publication is: Claudin-1 regulates intestinal epithelial homeostasis through the modulation of Notch-signalling.
Publications
- Claudin-1 regulates intestinal epithelial homeostasis through the modulation of Notch-signalling.
- Cyclin D3 is essential for intestinal epithelial cell proliferation.
- Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer.
- Cell proliferation: a matter of time and place.
- Variability of in situ proteomic profiling and implications for study design in colorectal tumors.
- Smad4 regulates claudin-1 expression in a transforming growth factor-beta-independent manner in colon cancer cells.
- Department of Surgery, Vanderbilt University Medical Center, Nashville, Tenn.
- Smad3 has a critical role in TGF-beta-mediated growth inhibition and apoptosis in colonic epithelial cells.
- Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer.
- Resident work hour limits and patient safety.
- BVES regulates EMT in human corneal and colon cancer cells and is silenced via promoter methylation in human colorectal carcinoma.
- Transformation of rat intestinal epithelial cells by overexpression of Rab25 is microtubule dependent.
- Urine PGE-M: A metabolite of prostaglandin E2 as a potential biomarker of advanced colorectal neoplasia.
- Smad4-dependent regulation of urokinase plasminogen activator secretion and RNA stability associated with invasiveness by autocrine and paracrine transforming growth f...
- Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer.
- Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer.
- Dysregulation of E-cadherin by oncogenic Ras in intestinal epithelial cells is blocked by inhibiting MAP kinase.
- Neoadjuvant concurrent paclitaxel and radiation in stage II/III breast cancer.
- Identification of early intestinal neoplasia protein biomarkers using laser capture microdissection and MALDI MS.
- The use of a multidisciplinary morbidity and mortality conference to incorporate ACGME general competencies.
- Identification and optimization of small molecules that restore E-cadherin expression and reduce invasion in colorectal carcinoma cells.
- Smad4-Mediated Signaling Inhibits Intestinal Neoplasia by Inhibiting Expression of ?-Catenin.
- Claudin-1 up-regulates the repressor ZEB-1 to inhibit E-cadherin expression in colon cancer cells.
- Oncogenic Ras and transforming growth factor-beta synergistically regulate AU-rich element-containing mRNAs during epithelial to mesenchymal transition.
- Enhanced tumor formation in cyclin D1 x transforming growth factor beta1 double transgenic mice with characterization by magnetic resonance imaging.
- The changing roles of a surgical department chair: adapting to a changing environment.
- Preoperative lymphoscintigraphy and internal mammary sentinel lymph node biopsy do not enhance the accuracy of lymphatic mapping for breast cancer.
- Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas.
- Correlation of Skp2 with carcinogenesis, invasion, metastasis, and prognosis in colorectal tumors.
- A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers.
- Regulation of cyclooxygenase-2 expression by the translational silencer TIA-1.
- Oncogenic Ras dominates overexpression of E-cadherin in malignant transformation of intestinal epithelial cells.
- Identification and isolation of candidate human colonic clonogenic cells based on cell surface integrin expression.
- New strategies for colorectal cancer prevention and treatment.
- Induction of cyclooxygenase-2 and invasiveness by transforming growth factor-beta(1) in immortalized mouse colonocytes expressing oncogenic Ras.
- Vascular endothelial growth factor-mediated angiogenesis inhibition and postoperative wound healing in rats.
Schools
University of Texas At Galveston Medical Branch
University Tex Med Br
Vanderbilt University
Doctors Specialties
- Critical Care Surgery
- Radiology
Accepted Insurances
Awards
- America's Top Doctors
- Nashville Lifestyles Magazine
- America's Top Doctors for Cancer
- Elected Member
- Redbook Magazine: Top Breast Cancer Doctors
Education
-
Emory University -
University of Texas Medical Branch
Hospital
-
Vanderbilt Hospital and Clinics
Drug Facts
| NPI NUMBER | 1275632606 | |
| NPPES Provider LastName | BEAUCHAMP | |
| NPPES Provider FirstName | ROBERT | |
| NPPES Provider ZIPCode | 372320001 | |
| NPPES Provider State | TN | |
| Specialty Description | Surgical Oncology | |
| Total Claim Count | 11.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1275632606 |
| Last Name Of The Provider | BEAUCHAMP |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
|
Dr. Kyla Terhune, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kurt V. Berger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leann Stokes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James McElmurray, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew A. Day, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adam R. Guttentag, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mayur B. Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert J. Behm, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kaushik Mukherjee, MD |
|
|
Dr. Jennifer L. Williams, MD |
|
|
Dr. Ronald D. Collier, MD |